These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2071288)

  • 1. Stimulatory effects of FK156 in a panel of tests designed to detect changes in immune function.
    Weston BJ; Henderson DC; Seal S; Spackman V; Robertson F; Dewdney JM
    Int J Immunopharmacol; 1991; 13(2-3):117-24. PubMed ID: 2071288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage involvement in the antitumor activity of a synthetic acyltripeptide (FK-565) against experimental lung carcinoma metastases.
    Schultz RM; Altom MG
    J Immunopharmacol; 1986; 8(4):515-28. PubMed ID: 3543138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of subchronic d-fenfluramine on splenic immune functions in young and old male and female Fischer 344 rats.
    Clancy J; Petrovic LM; Gordon BH; Handa RJ; Campbell DB; Lorens SA
    Int J Immunopharmacol; 1991; 13(8):1203-12. PubMed ID: 1814854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and adjuvant activity of FK-156 analogues: acyl derivatives of N-[N2-(L-alanyl-gamma-D-glutamyl)-2(L),2'(D)-diamino-1-pimeloyl ]glycine.
    Okada S; Takeno H; Hemmi K; Kitaura Y; Hashimoto M
    Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):889-92. PubMed ID: 4017131
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoactive peptides, FK 156 and FK 565. IV. Activation of mouse macrophages.
    Watanabe Y; Tawara S; Mine Y; Kikuchi H
    J Antibiot (Tokyo); 1985 Dec; 38(12):1781-7. PubMed ID: 3005214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New convenient synthesis of immunostimulating peptides containing meso-diaminopimelic acid. Syntheses of FK-565 and FK-156.
    Kolodziejczyk AM; Kolodziejczyk AS; Stoev S
    Int J Pept Protein Res; 1992 Apr; 39(4):382-7. PubMed ID: 1428528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CI-949, a novel antiallergy agent, on immune function of male Fischer 344 rats.
    Bleavins MR; de la Iglesia FA; Munson AE; McCay JA; Stern ML; Fuchs BA; White KL
    J Pharmacol Exp Ther; 1991 Apr; 257(1):316-22. PubMed ID: 2019994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation by a new synthetic acyltripeptide and its analogs entrapped in liposomes of rat alveolar macrophages to the tumor cytotoxic state.
    Sone S; Mutsuura S; Ogawara M; Utsugi T; Tsubura E
    Cancer Immunol Immunother; 1984; 18(3):169-73. PubMed ID: 6568873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of conformationally constrained γ-D-glutamyl-meso-diaminopimelic acid derivatives as ligands of nucleotide-binding oligomerization domain protein 1 (Nod1).
    Jakopin Ž; Gobec M; Kodela J; Hazdovac T; Mlinarič-Raščan I; Sollner Dolenc M
    Eur J Med Chem; 2013 Nov; 69():232-43. PubMed ID: 24044936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune function assays as indicators of chromate exposure.
    Snyder CA; Valle CD
    Environ Health Perspect; 1991 May; 92():83-6. PubMed ID: 1834456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro.
    Ahmed K; Turk JL
    Cancer Immunol Immunother; 1989; 28(2):87-92. PubMed ID: 2783891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating effects of the synthetic thymic dipeptide pidotimod on the immune system in the aging rat.
    Chiarenza A; Iurato MP; Barbera N; Lempereur L; Cantarella G; Scapagnini U; Bernardini R
    Pharmacol Toxicol; 1994; 74(4-5):262-6. PubMed ID: 8090697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N2-(gamma-D-Glutamyl)-meso-2(L),2'(D)-diaminopimelic acid as the minimal prerequisite structure of FK-156: its acyl derivatives with potent immunostimulating activity.
    Kitaura Y; Nakaguchi O; Takeno H; Okada S; Yonishi S; Hemmi K; Mori J; Senoh H; Mine Y; Hashimoto M
    J Med Chem; 1982 Apr; 25(4):335-7. PubMed ID: 7069711
    [No Abstract]   [Full Text] [Related]  

  • 14. Ex vivo and in vivo characterization of biological response modifiers (BRMs).
    Masihi KN; Talmadge JE
    Dev Biol Stand; 1992; 77():143-5. PubMed ID: 1426655
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of pidotimod on the function of the human immune system: in vitro and ex vivo study].
    Borghi MO; Minonzio F; Fain C; Carbonelli V; Barcellini W; Del Papa N; La Rosa L; Piona A; Gambini D; Meroni PL
    Drugs Exp Clin Res; 1993; 19 Suppl():37-43. PubMed ID: 8625781
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitogenic activity of a water-soluble adjuvant (Bu-WSA) obtained from Bacterionema matruchotii. IV. Synergistic effects of Bu-WSA on Concanavalin A-induced proliferative response of human peripheral blood lymphocytes.
    Nitta T; Okumura S; Tsushi M; Nakano M
    Microbiol Immunol; 1982; 26(7):585-97. PubMed ID: 6982390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements.
    Nio DA; Moylan RN; Roche JK
    J Immunol; 1993 Jun; 150(12):5281-8. PubMed ID: 8515059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
    Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
    Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of bis(tri-n-butyltin)oxide in the rat. II. Suppression of thymus-dependent immune responses and of parameters of nonspecific resistance after short-term exposure.
    Vos JG; de Klerk A; Krajnc EI; Kruizinga W; van Ommen B; Rozing J
    Toxicol Appl Pharmacol; 1984 Sep; 75(3):387-408. PubMed ID: 6474470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.